Intelligence drugs and the social valuation of cognitive abilities: irresponsible prescribing and frustrated Pygmalion
Article Sidebar
Main Article Content
Abstract
.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Rose SP. ‘Smart drugs’: do they work? Arethey ethical? Will they be legal? Nat RevNeurosci 2002; 3: 975-9
Ricci S, Celani MG, Cantisani TA y col.Piracetam in acute stroke: a systematic review. JNeurol. 2000; 247:263-6.
Flicker L, Grimley Evans G. Piracetam fordementia or cognitive impairment. CochraneDatabase Syst Rev. 2001;(2):CD001011.
Noorbala AA, Akhondzadeh S, Davari-Ashtiani R y col. Piracetam in the treatment ofschizophrenia: implications for the glutamatehypothesis of schizophrenia. J Clin Pharm Ther1999; 24: 369-74.
Ruthrich H, Grecksch G, Krug M. Effects ofpiracetam on pentylenetetrazol-kindlingdevelopment, hippocampal potentiationphenomena and kindling-induced learningdeficit. Naunyn Schmiedebergs Arch Pharmacol1999; 360: 413-20
Vaglenova J, Vesselinov Petkov V. Cannootropic drugs be effective against the impact ofethanol teratogenicity on cognitive performance?Eur Neuropsychopharmacol 2001; 11: 33-40.BIBLIOGRAFÍA
Rauca C, Jantze H, Krug M. Does fucose orpiracetam modify the effect of hypoxiapreconditioning against pentylenetetrazol-induced seizures? Brain Res 2000; 880: 187-90.
Stoppe G, Sandholzer H, Staedt J y col.Factors influencing the prescribing of nootropicdrugs. Results of a representative inquiry inLower Saxony. Dtsch Med Wochenschr 1995;120: 1614-9.
Borges JL. Funes el memorioso. En: Ficcio-nes. Buenos Aires: Emece, 2004